Filter
329
Text search:
pfizer
Featured
Recommendations
41
New Publications
16
Language
Document type
Studies & Reports
78
No document type
76
Guidelines
71
Fact sheets
41
Manuals
21
Strategic & Response Plan
15
Resource Platforms
8
Training Material
5
Situation Updates
5
Videos
4
Online Courses
3
Infographics
2
Countries / Regions
Brazil
14
Russia
11
Germany
9
Argentina
9
South Africa
8
Ukraine
7
Middle East and North Africa
7
Latin America and the Carribbean
7
Mozambique
6
Global
6
India
5
Chile
5
Africa
5
Ecuador
4
Senegal
3
China
3
Colombia
3
East and Southern Africa
3
West and Central Africa
3
Western and Central Europe
3
Paraguay
3
Liberia
2
Nigeria
2
Philippines
2
Kenya
2
Indonesia
2
Peru
2
El Salvador
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Ghana
1
Uganda
1
Somalia
1
Nepal
1
South Sudan
1
Syria
1
Chad
1
Tanzania
1
Sudan
1
Benin
1
Angola
1
Yemen
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Iran
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
18
Women & Child Health
7
Public Health
6
Key Resources
4
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
154
Mental Health
30
NTDs
30
HIV
16
TB
15
AMR
12
Refugee
8
NCDs
8
Global Health Education
6
Disability
4
Health Financing Toolbox
4
Caregiver
3
Rapid Response
2
Pharmacy
2
Ebola & Marburg
1
Conflict
1
Zika
1
Planetary Health
1
2.0 Rapid Response
1
Como solicitar, administrar y gestionar exitosamente la donación de Zithromax® para la eliminación de tracoma
Comment réussir à demander, administrer et gérer les dons de Zithromax® pour l’élimination du trachome
Como aplicar, administrar e gerir com sucesso a doação Zithromax® para eliminação do tracoma
Trachoma is the world’s leading infectious cause of blindness. It is one of 18 neglected
tropical diseases (NTDs) that affect over one billion of the world’s poorest people.
Twenty-Fourth Annual Trachoma Control Program Review, Summary Proceedings
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
La prévalence de la covid -19 chez la femme enceinte et les accouchées semble être faible. Elles étaient asymptomatiques et le pronostic maternel était satisfaisant. Néanmoins, le risque de for.pdf
3 March 2016
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This
...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k
...
